Literature DB >> 15642781

Multistep differentiation of GH-producing cells from their immature cells.

C Mogi1, H Goda, K Mogi, A Takaki, K Yokoyama, M Tomida, K Inoue.   

Abstract

In order to study GH cell differentiation, we used the clonal cell lines called MtT/E and MtT/S cells, which were derived from a rat mammotrophic pituitary tumor. Although MtT/E cells are non-hormone-producing ones, Pit-1 protein is present in their nuclei, which suggests that MtT/E cells are progenitor cells of the Pit-1 cell lineage and have the potential to differentiate into hormone-producing cells. On the other hand, MtT/S cells produce GH; however, the responsiveness to GH-releasing hormone (GHRH) is weak and only a small number of secretory granules are present in their cytoplasm, which suggests that MtT/S cells are premature GH cells. In order to differentiate into GH cells from MtT/E cells as a progenitor cell, we examined several differentiation factors and found that retinoic acid (RA) induced the differentiation of MtT/E cells into GH-producing cells. RA-induced GH cells partially matured with the glucocorticoid treatment; however, the responsiveness to GHRH on GH secretion was incomplete. In order to elucidate the mechanism underlying full differentiation of GH cells, we used MtT/S cells. We treated MtT/S cells with glucocorticoid and found that they differentiated into mature GH cells with many secretory granules in their cytoplasm and they responded well to GHRH. These results suggested that MtT/E and MtT/S cells are progenitor or premature GH cells, and show different responses to differentiation factors. Our data also suggested that GH cells differentiate from their progenitor cells through multistep processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642781     DOI: 10.1677/joe.1.05870

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat.

Authors:  Ken Fujiwara; Bulgan Davaadash; Megumi Yatabe; Motoshi Kikuchi; Kotaro Horiguchi; Kenji Kusumoto; Tom Kouki; Takashi Yashiro
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

3.  PROP1-Dependent Retinoic Acid Signaling Regulates Developmental Pituitary Morphogenesis and Hormone Expression.

Authors:  Leonard Y M Cheung; Sally A Camper
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

4.  Role of Ras, ERK, and Akt in glucocorticoid-induced differentiation of embryonic rat somatotropes in vitro.

Authors:  Wen Ming Lv; Yan Zhao; Guang Yang; Shi Yun Dong; Guang Hui Zhang; Yu Zhang; Guo Zhong Li; Yu Cheng
Journal:  Mol Cell Biochem       Date:  2014-02-20       Impact factor: 3.396

5.  Isolation of tumour stem-like cells from benign tumours.

Authors:  Q Xu; X Yuan; P Tunici; G Liu; X Fan; M Xu; J Hu; J Y Hwang; D L Farkas; K L Black; J S Yu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

6.  Atrazine binds to the growth hormone-releasing hormone receptor and affects growth hormone gene expression.

Authors:  Walid D Fakhouri; Joseph L Nuñez; Frances Trail
Journal:  Environ Health Perspect       Date:  2010-06-08       Impact factor: 9.031

7.  Somatotropes maintain their immature cells through Insulin-like growth factor I (IGF-I).

Authors:  Kotaro Yokoyama; Chihiro Mogi; Kaoru Miura; Keisuke Kuroda; Kinji Inoue
Journal:  Endocr Pathol       Date:  2007       Impact factor: 4.056

8.  Involvement of GPR4 in increased growth hormone and prolactin expressions by extracellular acidification in MtT/S cells.

Authors:  Shiori Musha; Saishu Yoshida; Syo Murakami; Ryotaro Kojima; Masahito Deai; Naoshi Saso; Chihiro Mogi; Koichi Sato; Fumikazu Okajima; Hideaki Tomura
Journal:  J Reprod Dev       Date:  2020-01-19       Impact factor: 2.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.